Shandong Xinhua Pharmaceutical Company Limited 배당금 정보
Shandong Xinhua Pharmaceutical Company Limited는 주당 0.3328의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 반기별에 지급되며, 마지막 배당금 지급일은 Jul 18, 2025였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.3328
Jul 18, 2025
지급 빈도
지급 비율
반기별
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Jul 18, 2025
$0.25
Jul 17, 2025
Jul 18, 2025
Sep 27, 2024
$0.025
Sep 26, 2024
Sep 27, 2024
Jul 30, 2024
$0.25
Jul 29, 2024
Jul 30, 2024
Jul 26, 2023
$0.20
Jul 25, 2023
Jul 26, 2023
Aug 5, 2022
$0.15
Aug 4, 2022
Aug 5, 2022
Jul 30, 2021
$0.15
Jul 29, 2021
Jul 30, 2021
배당금 차트
SHNXY 배당금
SHNXY 배당금 성장률(년간 비교)
Follow-Up Questions
Shandong Xinhua Pharmaceutical Company Limited의 현재 배당금과 연간 배당금은 얼마인가요?
Shandong Xinhua Pharmaceutical Company Limited의 배당 성향은 얼마인가요?
SHNXY의 배당락일은 언제인가요?
Shandong Xinhua Pharmaceutical Company Limited은 얼마나 자주 배당금을 지급하나요?
주요 통계
이전 종가
$18.19
시가
$18.19
일일 범위
$18.19 - $18.19
52주 범위
$18.19 - $18.19
거래량
100
평균 거래량
0
EPS(TTM)
0.80
배당수익률
--
시가총액
$899.9M
SHANDONG XINHUA PHARMACEUTICAL 란 무엇인가요?
Shandong Xinhua Pharmaceutical Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zibo, Shandong and currently employs 7,296 full-time employees. Shandong Xinhua Pharmaceutical Co Ltd is a China-based company mainly engaged in the development, manufacturing and sales of chemical raw materials, pharmaceutical preparations and chemical products. The firm operates three segments. The Chemical Raw Materials segment is mainly engaged in the development, manufacturing and sales of raw materials for antipyretics and analgesics such as caffeine series, ibuprofen series, aspirin series, dopamine series, barbiturates and pipemidic acid. The Pharmaceutical Preparations segment is mainly engaged in the development, manufacturing and sales of tablets, injections and capsules such as pipemidic acid tablets, aminopyrine and nimodipine tablets. The Pharmaceutical Intermediates and Other Products segment is mainly engaged in the development, manufacturing and sales of pharmaceutical intermediates and other products. The firm mainly operates its business in the domestic market and overseas markets such as the Americas and Europe.